OncoInfluencers to Follow on Social Media: Dr. Khalid El Bairi
We’re pleased to feature Dr. Khalid El Bairi, a leading expert in clinical and translational oncology research, as our next oncoInfluencer.
About Dr. Khalid El Bairi
Khalid El Bairi, founder of The Cancer Biomarkers Working Group, specializes in clinical and translational research in medical oncology. With many peer-reviewed articles, he delves into predictive and prognostic cancer biomarkers, especially for digestive and gynecological cancers like ovarian and colorectal malignancies. El Bairi holds board positions in international scientific societies such as IGCS, ESMO, ASCO, ESGO, and AACR. Serving as editor and reviewer for over 40 journals, he also educates medical and Ph.D. students on evidence-based medicine, research methodologies, and publishing ethics.
Dr. Khalid El Bairi actively shares insights from his extensive research in cancer biomarkers and oncology on X/Twitter and LinkedIn. His posts delve into key topics such as predictive and prognostic biomarkers for digestive and gynecological cancers, advancements in personalized cancer treatment, and the latest trends in clinical and translational research. Dr. El Bairi’s updates also focus on the importance of evidence-based medicine, research methodologies, and innovations in cancer diagnostics.
Follow Dr. Khalid El Bairi on X/Twitter and LinkedIn to stay updated on his groundbreaking work in cancer biomarkers, oncology research, and his contributions to the global scientific community.
Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023